Vitrocap is a supplement for specific use as an eye floaters treatment. In this video I unbox Vitrocap product and explore its claims as an eye floaters treatment. I explore the research I discovered on Vitrocap and it’s claim to help eye floaters symptoms.
Vitrocap is interesting because if you’ve got floaters in the eye you will know how annoying they can be and you may have searched for an effective eye floaters treatment that doesn’t include eye surgery such as Yag laser, vitrectomy or even novel ideas like the eye floaters pineapple cure.
The question is whether this eye floaters remedy (and possible eye floaters natural remedy) can mean eye floaters no more and really deliver on all types of eye floaters; from posterior vitreous detachment (PVD) floaters to standard age related eye floaters.
Research published in the ophthalmology journal discovered suggests that this could be an eye floater cure and the research included retina scans. Traditional eye floater treatment is carried out by an ophthalmologist and includes vitrectomy (which may carry risk of retinal detachment) and Yag laser (which may carry risk of vitreous detachment or more smaller floater fragments).
The purpose of looking into this product is to find out if you can say good bye to your eye floaters symptoms and experience eye floaters no more.
The study included 32 patients, 16 of whom were in the main group (5 men and 11 women between the ages of 37 and 57). They complained about floating flies, cobwebs, egg yolks, mesh, spiders in front of their eyes, which had emerged or intensified in the last 1-6 months.
The control group included patients who had a moderate number of clouding in the CT on B-scanning, but they did not make active complaints against them.
Patients of the main group received the drug “Vitrocap” according to the scheme: 1 capsule once a day for three months, in the monitoring group for the period of dynamic observation (3 months) the drug was not prescribed. Since complaints of clouding in patients in this group were leading, we analysed their nature before and after the course of the drug “Vitrocap“.
The study developed and used a conditional scale of to determine the level of visual discomfort caused by their main complaint – from one to four, where…
1 – discomfort (“I can’t work, give sick leave”)
2 – “I see clouding every day, interfere with active visual work”
3 – “I see confusion, I notice occasionally”
4 – “I don’t see any clouding.”
Patients of the main group received the drug “Vitrocap” according to the scheme: 1 capsule once a day for three months, in the monitoring group for the period of dynamic observation (3 months) the drug was not prescribed.
Question For You: Would you try VitroCap or would you consider surgical options for your eye floaters instead?
The results of the study showed that after the Vitrocap course patients reported a reduction or absence of “floaters” complaints in 76% of cases, and according to A-scan characteristics (the number and height of echogenicity peaks) there were quantitative and qualitative improvements in 32% and 80% of cases, correspondingly.
Notable finding stated in their results:
Our observations confirm that the active substances of the drug “Vitrocap” help to partially “dissolve” the existing clouding of CT, as well as prevent the formation of new ones.
Conclusion:
The drug “Vitrocap” increases the level of comfort of vision and in most cases reduces subjective complaints about flies in front of the eyes, so can be used in the clinical practice of an ophthalmologist.
According to objective data of echo-graphic combined A- and B-scanning after one course of the drug “Vitrocap” revealed a tendency to reduce the number of clouding in CT, as well as change their quality characteristics.
Drug therapy (Vitrocap) helps to reduce the severity of behavioural reactions in patients with DST, as the process of treatment has a beneficial effect on their emotional state.
In conclusion, the data obtained are preliminary. Treatment of CT destruction by the drug “Vitrocap” requires further study and additional clinical study to confirm the long-term and statistically significant result.
So the product Vitrocap seems to help minimise the visibility of eye floaters subjectively and objectively, although the study team do rightly suggest a deeper study is required.
Resources & credits mentioned in video:
- Research journal (use google translate if needed) : https://journals.eco-vector.com/ov/article/view/11875
- Vitrocap website: https://www.ebiga-vision.com/en/vitrocap/
